天美传媒

Qualifications
Doctor of Philosophy (University of Queensland)

Professional memberships
and associations
Board Member of International Society of Exercise and Immunology (www.isei.dk)
Member of American Physiological Society (www.the-aps.org)
F1000 Prime Faculty Member (Muscle & Connective Tissue)
Associate Editor of Exercise Immunology Review
Editorial Board Member of Frontiers in Sports and Exercise Nutrition
Senior Research Affiliate, Queensland Academy of Sport
Honorary Senior Research Fellow, School of Human Movement and Nutrition Sciences, University of Queensland

Exercise and diet, energy balance, metabolism, and chronic metabolic disease, cardiometabolic health, Non-Alcoholic Fatty Liver Disease.

James had expertise in the interaction between exercise and the neuro-endocrine regulation of appetite & energy balance. He has also researched chronic metabolic disease, cardiometabolic health, and appetite and energy balance.

Dr. Diego Hernández-Saavedra received his BS Degree in Pharmaceutical Biological Chemistry from the Autonomous University of Queretaro, Mexico in 2012. Thereafter, he completed his Ph.D. degree in Nutritional Sciences at the University of Illinois in 2018. After completing his Ph.D., he went to The Ohio State University Wexner Medical Center to complete his postdoctoral training in 2021. Dr. Hernández-Saavedra’s research program focuses on the beneficial effects of exercise to understand the adaptations in key metabolites and lipids in health and disease, the epigenetic mechanisms associated exercise that improve metabolism and bioenergetics, and the transgenerational effect of sedentarism and exercise on metabolism and cardiac function.

Using an interprofessional team approach to research, Akers and his team study different nutrition interventions and exercise modalities to help individuals prevent and treat chronic diseases and to improve their health-related quality of life. Akers’s team also examines various nutrition manipulations to improve athletic performance.
Akers is passionate about teaching undergraduate and graduate students about the research process.
Akers earned his doctorate in nutrition in chronic disease at Virginia Tech, his master's in nutritional and physical activity at JMU and his bachelor's in clinical dietetics at Radford.

Dr. Mehmood Khan’s distinguished career has included several senior corporate roles, including Vice Chairman and Chief Scientific Officer of Global Research and Development at PepsiCo, and President of Global R&D at Takeda Pharmaceuticals.
Before moving into the private sector Dr. Khan was a faculty member in endocrinology at the Mayo Clinic and Medical School, where he served as Director of the Diabetes, Endocrine and Nutritional Trials Unit. He also led programs in diabetes, endocrinology, metabolism, and nutrition in Minneapolis.
Dr. Khan is a member of the Board of Directors of Reckitt Benckiser and of the Saudi Research, Development, and Innovation Authority (RDIA), Executive Chairman of Life Biosciences, a member of the Saudi National Biotechnology Strategy Steering Committee, and Chairman of the Visiting Committee on Advanced Technology of the United States’ National Institute of Standards and Technology (NIST).
Dr. Khan earned his medical degree from the University of Liverpool School of Medicine, England, and completed a fellowship in clinical endocrinology and nutrition in the Department of Medicine and Food Science and Nutrition at the University of Minnesota, Minneapolis. He is a Fellow of the Royal College of Physicians in London, a Fellow of the American College of Endocrinology, and an Elected Fellow in the Department of Pharmacology at University of Oxford.

Auinash (Nash) Kalsotra is a professor and Willam C. Rose Scholar of Biochemistry in the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. He also is an adjunct professor in the Division of Nutritional Sciences, Cancer Center@Illinois, and Carl R. Woese Institute for Genomic Biology. 
Kalsotra is a Chan Zuckerburg Biohub Chicago investigator, a Beckman Institute fellow, and an associate editor of the WIREs RNA journal (Wiley).
He received his undergraduate degree in pharmacy from the Birla Institute of Technology and Science, Pilani, India (1999). While earning his PhD at the University of Texas MD Anderson Cancer Center, he was a Harry S. and Isabel Cameron doctoral fellow and studied the role of cytochromes P450 in the progression and resolution of inflammation. During his postdoctoral work as a Myotonic Dystrophy Foundation fellow and an American Heart Association young investigator at Baylor College of Medicine, he began his studies on post-transcriptional gene regulation and RNA biology in human health and disease. Kalsotra started his independent research group in 2013.
He teaches MCB 354: The Biochemical and Physical Basis of Life, a course with large enrolments of over more than 400 students each academic yera. As a junior faculty mentor and advisor, he provides guidance and support to pre-tenured faculty in the School of Molecular and Cellular Biology.
As an active member of the RNA Society, Kalsotra has organized/chaired scientific sessions at various national and international meetings. He also serves as an expert reviewer for several funding agencies and journals. Additionally, as a steering committee member of the Rustbelt RNA community, he is involved in guiding RNA research in the Midwest, promoting long-term efforts to ensure the viability of the annual RRM conference, and fostering the professional development of students from smaller universities and predominantly undergraduate institutions.
Research interests
Kalsotra’s research interests are to uncover the biological function(s) of RNA in tissue development, regeneration, and disease. He is particularly interested in understanding:

how various RNA processing mechanisms integrate with transcriptional, translational, and metabolic programs to ensure normal tissue growth and function,
why misregulation of these mechanisms results in disease, and
whether they can be leveraged to prevent or reverse particular human disorders.

Recent work from the Kalsotra laboratory has resulted in many high-profile publications, e.g., Genes & Dev., J. Exp. Med, Genome Res., Dev. Cell, J. Clin. Invest., PNAS, Nature Struct. Mol. Biol., eLife, and Nature Commun. He has also published invited articles, including perspectives and opinions in Nature Reviews, Curr. Opin. Genet. Dev., Semin. Cell Dev. Biol. Kalsotra is regularly invited to present his research findings at major conferences, universities, and research centers. His research activities have been funded by grants from the National Institutes of Health, Department of Defense, Muscular Dystrophy Association, Chan Zuckerburg Initiative, March of Dimes, and American Heart Association.
 
Website